Wikidata entity: Q58396
C₁₉H₂₄N₂ (P274)
Quantities
| P2067 | mass | 280.194 |
| P3780 | active ingredient in | ... | Q47522214 (Tofranil) | Tofranil |
| P233 | canonical SMILES | String | CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31 | ??? |
| P373 | Commons category | String | Imipramine | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Imipramine-3D-balls.png | ??? |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P8026 | LiverTox likelihood score | ... | Q83284157 (LiverTox toxicity likelihood category B) | LiverTox toxicity likelihood category B |
| P2175 | medical condition treated | ... | Q81938 (pain) | pain |
| P2175 | medical condition treated | ... | Q181923 (attention deficit hyperactivity disorder) | attention deficit hyperactivity disorder |
| P2175 | medical condition treated | ... | Q4340209 (depression) | depression |
| P2175 | medical condition treated | ... | Q19000444 (neurotic disorder) | neurotic disorder |
| P2175 | medical condition treated | ... | Q741713 (panic disorder) | panic disorder |
| P129 | physically interacts with | ... | Q410142 (solute carrier family 6 member 4) | solute carrier family 6 member 4 |
| P129 | physically interacts with | ... | Q4847910 (Cholinergic receptor muscarinic 2) | Cholinergic receptor muscarinic 2 |
| P129 | physically interacts with | ... | Q7050954 (Solute carrier family 6 member 2) | Solute carrier family 6 member 2 |
| P129 | physically interacts with | ... | Q21110532 (Potassium voltage-gated channel subfamily H member 1) | Potassium voltage-gated channel subfamily H member 1 |
| P129 | physically interacts with | ... | Q21497878 (Potassium inwardly-rectifying channel, subfamily J, member 6) | Potassium inwardly-rectifying channel, subfamily J, member 6 |
| P129 | physically interacts with | ... | Q21497881 (Potassium inwardly-rectifying channel, subfamily J, member 5) | Potassium inwardly-rectifying channel, subfamily J, member 5 |
| P3489 | pregnancy category | ... | Q3679261 (Australian pregnancy category C) | Australian pregnancy category C |
| P3489 | pregnancy category | ... | Q28123621 (US pregnancy category N) | US pregnancy category N |
| P769 | significant drug interaction | ... | Q568 (lithium) | lithium |
| P769 | significant drug interaction | ... | Q58397 (amitriptyline) | amitriptyline |
| P769 | significant drug interaction | ... | Q58614 (loxapine) | loxapine |
| P769 | significant drug interaction | ... | Q58713 (clomipramine) | clomipramine |
| P769 | significant drug interaction | ... | Q132621 (epinephrine) | epinephrine |
| P769 | significant drug interaction | ... | Q144085 (pimozide) | pimozide |
| P769 | significant drug interaction | ... | Q174259 (droperidol) | droperidol |
| P769 | significant drug interaction | ... | Q45050 (tenoxicam) | tenoxicam |
| P769 | significant drug interaction | ... | Q55434 (pethidine) | pethidine |
| P769 | significant drug interaction | ... | Q244408 (Diclofenac) | Diclofenac |
| P769 | significant drug interaction | ... | Q251347 (haloperidol) | haloperidol |
| P769 | significant drug interaction | ... | Q221361 (clozapine) | clozapine |
| P769 | significant drug interaction | ... | Q228143 (zuclopenthixol) | zuclopenthixol |
| P769 | significant drug interaction | ... | Q186969 (ibuprofen) | ibuprofen |
| P769 | significant drug interaction | ... | Q179996 ((RS)-methadone) | (RS)-methadone |
| P769 | significant drug interaction | ... | Q181003 (tryptophan) | tryptophan |
| P769 | significant drug interaction | ... | Q409231 (indomethacin) | indomethacin |
| P769 | significant drug interaction | ... | Q409236 (fluvoxamine) | fluvoxamine |
| P769 | significant drug interaction | ... | Q409595 (isocarboxazid) | isocarboxazid |
| P769 | significant drug interaction | ... | Q409672 ((RS)-citalopram) | (RS)-citalopram |
| P769 | significant drug interaction | ... | Q414463 (tapentadol) | tapentadol |
| P769 | significant drug interaction | ... | Q418656 (procarbazine) | procarbazine |
| P769 | significant drug interaction | ... | Q186242 (norepinephrine) | norepinephrine |
| P769 | significant drug interaction | ... | Q347941 (parecoxib) | parecoxib |
| P769 | significant drug interaction | ... | Q1215575 (naproxen) | naproxen |
| P769 | significant drug interaction | ... | Q1747559 (phenelzine) | phenelzine |
| P769 | significant drug interaction | ... | Q2465218 ((RS)-etodolac) | (RS)-etodolac |
| P769 | significant drug interaction | ... | Q410291 (verapamil) | verapamil |
| P769 | significant drug interaction | ... | Q411377 (linezolid) | linezolid |
| P769 | significant drug interaction | ... | Q411932 ((S)-duloxetine) | (S)-duloxetine |
| P769 | significant drug interaction | ... | Q2555245 ((RS)-fenoprofen) | (RS)-fenoprofen |
| P769 | significant drug interaction | ... | Q3563148 (vortioxetine) | vortioxetine |
| P769 | significant drug interaction | ... | Q422229 (diltiazem) | diltiazem |
| P769 | significant drug interaction | ... | Q422244 (fluoxetine) | fluoxetine |
| P769 | significant drug interaction | ... | Q402633 ((±)-deprenyl) | (±)-deprenyl |
| P769 | significant drug interaction | ... | Q407541 (fentanyl) | fentanyl |
| P769 | significant drug interaction | ... | Q419890 ((±)-flurbiprofen) | (±)-flurbiprofen |
| P769 | significant drug interaction | ... | Q420885 (tranylcypromine) | tranylcypromine |
| P769 | significant drug interaction | ... | Q421934 (moclobemide) | moclobemide |
| P769 | significant drug interaction | ... | Q421937 ((RS)-hydroxyzine) | (RS)-hydroxyzine |
| P769 | significant drug interaction | ... | Q412221 (clonidine) | clonidine |
| P769 | significant drug interaction | ... | Q413591 (sotalol) | sotalol |
| P769 | significant drug interaction | ... | Q414028 (meloxicam) | meloxicam |
| P769 | significant drug interaction | ... | Q5613599 (guanfacine) | guanfacine |
| P769 | significant drug interaction | ... | Q422970 ((±)-promethazine) | (±)-promethazine |
| P769 | significant drug interaction | ... | Q423364 (propranolol) | propranolol |
| P769 | significant drug interaction | ... | Q407592 (tramadol) | tramadol |
| P769 | significant drug interaction | ... | Q407617 (sertraline) | sertraline |
| P769 | significant drug interaction | ... | Q407972 (chlorpromazine) | chlorpromazine |
| P769 | significant drug interaction | ... | Q408471 (paroxetine) | paroxetine |
| P769 | significant drug interaction | ... | Q408535 (quetiapine) | quetiapine |
| P769 | significant drug interaction | ... | Q408676 (piroxicam) | piroxicam |
| P769 | significant drug interaction | ... | Q425120 (disopyramide) | disopyramide |
| P769 | significant drug interaction | ... | Q425207 (nabumetone) | nabumetone |
| P769 | significant drug interaction | ... | Q481757 (aceclofenac) | aceclofenac |
| P769 | significant drug interaction | ... | Q599052 ((RS)-nefopam) | (RS)-nefopam |
| P769 | significant drug interaction | ... | Q834280 (bupropion) | bupropion |
| P769 | significant drug interaction | ... | Q408801 (celecoxib) | celecoxib |
| P769 | significant drug interaction | ... | Q409192 ((RS)-ketoprofen) | (RS)-ketoprofen |
| P769 | significant drug interaction | ... | Q898407 (venlafaxine) | venlafaxine |
| P769 | significant drug interaction | ... | Q958087 (labetalol) | labetalol |
| P769 | significant drug interaction | ... | Q963093 (sulindac) | sulindac |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q334477 (selective serotonin reuptake inhibitor) | selective serotonin reuptake inhibitor |
| P2868 | subject has role | ... | Q899668 (adrenergic uptake inhibitors) | adrenergic uptake inhibitors |
| P2868 | subject has role | ... | Q908843 (tricyclic antidepressant) | tricyclic antidepressant |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | imipramine | ??? |
Why not click here or view trends?
log id: 1851907